Mereo BioPharma (MREO) Shares Outstanding (2017 - 2026)

Mereo BioPharma (MREO) has reported Shares Outstanding (Entity) for 10 consecutive years, with $798.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) changed 0.39% year-over-year to $798.1 million; the TTM figure through Mar 2026 stood at $798.1 million (changed 0.39% YoY), while the FY2025 annual figure was $795.7 million, up 2.57% from the prior year.
• Shares Outstanding (Entity) held at $798.1 million in Q1 2026 per MREO's latest filing, from $795.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $798.1 million in Q1 2026 and bottomed at $584.9 million in Q2 2022.
• Historically, Shares Outstanding (Entity) has averaged $716.1 million across 5 years, with a median of $711.8 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) grew 17.63% — and 2026, when it grew 0.39%.
• Mereo BioPharma's Shares Outstanding (Entity) stood at $603.2 million in 2022, then climbed by 9.33% to $659.5 million in 2023, then grew by 17.63% to $775.7 million in 2024, then gained by 2.57% to $795.7 million in 2025, then increased by 0.3% to $798.1 million in 2026.
• Business Quant data shows MREO's Shares Outstanding (Entity) at $798.1 million in Q1 2026, $795.7 million in Q4 2025, and $795.5 million in Q3 2025.